ESPR
Esperion Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.15
-0.02 (-0.63%)
Rating:C-
Company Profile
CEO
Sheldon L. Koenig
IPO Date
2013-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.17
Prev. Close
$3.17
Day Low
$3.15
Day High
$3.17
52W Low
$0.95
52W High
$4.18
Market Cap
$0.65B
Volume
5.72M